InsidersTradesSigma
Follow the ICON PLC share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €13.1bn. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Among the most active insiders: Clerkin Nigel Bernard John. All data is free.
44
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€1m
34 ops.
Sell Volume
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,072 of 29,057 companies
39.1
score / 100
Value46
Quality32
FCF yld6.6%
Earn yld1.7%
EV/EBITDA20.2x
ROE0.3%
Gross mgn26%
Net mgn2.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations44 total
1,732 sharesOrdinary SharesSEC:0001628280-26-056301:0
3,375 sharesOrdinary SharesSEC:0001628280-26-056296:1
1,732 sharesOrdinary SharesSEC:0001628280-26-056304:0
1,732 sharesOrdinary SharesSEC:0001628280-26-056328:0
67 shares@ US$165.510.0001% mcap8.0% of flowOrdinary SharesSEC:0001628280-26-056301:4
237 shares@ US$162.720.0003% mcap10.4% of flowOrdinary SharesSEC:0001628280-26-056296:2
259 shares@ US$163.770.0003% mcap11.4% of flowOrdinary SharesSEC:0001628280-26-056296:3
1,591 shares@ US$164.470.0020% mcap70.3% of flowOrdinary SharesSEC:0001628280-26-056296:4
180 shares@ US$165.510.0002% mcap8.0% of flowOrdinary SharesSEC:0001628280-26-056296:5
87 shares@ US$162.720.0001% mcap10.2% of flowOrdinary SharesSEC:0001628280-26-056304:1
97 shares@ US$163.770.0001% mcap11.5% of flowOrdinary SharesSEC:0001628280-26-056304:2
590 shares@ US$164.470.0008% mcap70.2% of flowOrdinary SharesSEC:0001628280-26-056304:3
88 shares@ US$162.720.0001% mcap10.4% of flowOrdinary SharesSEC:0001628280-26-056321:1
96 shares@ US$163.770.0001% mcap11.4% of flowOrdinary SharesSEC:0001628280-26-056321:2
590 shares@ US$164.470.0008% mcap70.2% of flowOrdinary SharesSEC:0001628280-26-056321:3
67 shares@ US$165.510.0001% mcap8.0% of flowOrdinary SharesSEC:0001628280-26-056321:4
88 shares@ US$162.720.0001% mcap10.4% of flowOrdinary SharesSEC:0001628280-26-056324:1
96 shares@ US$163.770.0001% mcap11.4% of flowOrdinary SharesSEC:0001628280-26-056324:2
590 shares@ US$164.470.0008% mcap70.2% of flowOrdinary SharesSEC:0001628280-26-056324:3
280 shares@ US$162.720.0004% mcap10.4% of flowOrdinary SharesSEC:0001628280-26-056326:1
305 shares@ US$163.770.0004% mcap11.4% of flowOrdinary SharesSEC:0001628280-26-056326:2
1,880 shares@ US$164.470.0024% mcap70.3% of flowOrdinary SharesSEC:0001628280-26-056326:3
212 shares@ US$165.510.0003% mcap8.0% of flowOrdinary SharesSEC:0001628280-26-056326:4
95 shares@ US$162.720.0001% mcap10.3% of flowOrdinary SharesSEC:0001628280-26-056327:1
642 shares@ US$164.470.0008% mcap70.2% of flowOrdinary SharesSEC:0001628280-26-056327:3
25 of 44 declarations
About ICON PLC
ICON PLC is a clinical research organization that provides services to the pharmaceutical and biopharmaceutical industries. It specializes in drug development and the management of clinical trials.